SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹474 Cr | ₹414 Cr | ₹343 Cr | ₹369 Cr | ₹327 Cr |
What is the latest Long Term Provisions ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹474 Cr |
| Mar2024 | ₹414 Cr |
| Mar2023 | ₹343 Cr |
| Mar2022 | ₹369 Cr |
| Mar2021 | ₹327 Cr |
How is Long Term Provisions of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹474 Cr | 14.47 | |
| Mar2024 | ₹414 Cr | 20.70 | |
| Mar2023 | ₹343 Cr | -7.09 | |
| Mar2022 | ₹369 Cr | 12.82 | |
| Mar2021 | ₹327 Cr | - | |
Compare Long Term Provisions of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,747.3 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
| MANKIND PHARMA | ₹83,688.0 Cr | -2.6% | -5.6% | -15% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1.5% |
5.5% |
0.5% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses